Scarica l'app Stockscreener
7.21
3.89%
0.27
Dopo l'orario di chiusura:
7.35
0.14
+1.94%
Precedente Chiudi:
$6.94
Aprire:
$6.98
Volume 24 ore:
1.87M
Relative Volume:
1.37
Capitalizzazione di mercato:
$730.82M
Reddito:
-
Utile/perdita netta:
$-167.48M
Rapporto P/E:
-3.6974
EPS:
-1.95
Flusso di cassa netto:
$-197.47M
1 W Prestazione:
+10.92%
1M Prestazione:
+11.27%
6M Prestazione:
-40.95%
1 anno Prestazione:
-53.15%
Intervallo 1D:
$6.93
$7.33
Intervallo di 1 settimana:
$6.32
$7.33
Portata 52W:
$6.08
$16.76
Day One Biopharmaceuticals Inc Stock (DAWN) Company Profile
Nome
Day One Biopharmaceuticals Inc
Settore
Industria
Telefono
650 484-0899
Indirizzo
2000 SIERRA POINT PARKWAY, SUITE 501, BRISBANE
Confronta DAWN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DAWN
Day One Biopharmaceuticals Inc
|
7.21 | 665.95M | 0 | -167.48M | -197.47M | -1.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Day One Biopharmaceuticals Inc Stock (DAWN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-10-09 | Reiterato | Needham | Buy |
| 2024-08-01 | Aggiornamento | BofA Securities | Underperform → Buy |
| 2024-04-24 | Reiterato | Needham | Buy |
| 2023-04-25 | Downgrade | BofA Securities | Buy → Underperform |
| 2023-02-08 | Iniziato | CapitalOne | Overweight |
| 2023-02-03 | Iniziato | Oppenheimer | Perform |
| 2022-12-15 | Iniziato | H.C. Wainwright | Buy |
| 2022-12-14 | Iniziato | Needham | Buy |
| 2022-12-05 | Iniziato | Goldman | Buy |
| 2022-12-01 | Iniziato | BofA Securities | Buy |
Mostra tutto
Day One Biopharmaceuticals Inc Borsa (DAWN) Ultime notizie
Will Day One Biopharmaceuticals Inc. stock benefit from interest rate changesFree Bull & Bear Market Updates - jammulinksnews.com
When is the best time to buy Day One Biopharmaceuticals Inc. stockFree Bull & Bear Market Updates - jammulinksnews.com
Will Day One Biopharmaceuticals Inc. stock benefit from AI tech trendsConsistent high-performance stocks - jammulinksnews.com
Wall Street Analysts Believe Day One Biopharmaceuticals (DAWN) Could Rally 303.46%: Here's is How to Trade - Yahoo Finance
Arizona State Retirement System Reduces Stake in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World
BlackRock, Inc. Reduces Stake in Day One Biopharmaceuticals Inc - GuruFocus
What analysts say about Day One Biopharmaceuticals Inc. stockConsistently high yield - Autocar Professional
Day One Biopharmaceuticals Inc. Stock Analysis and ForecastBreakthrough profit margins - jammulinksnews.com
What makes Day One Biopharmaceuticals Inc. stock price move sharplyConsistent High Return Strategy - Newser
Is Day One Biopharmaceuticals Inc. a good long term investmentSkyrocketing profit margins - jammulinksnews.com
What drives Day One Biopharmaceuticals Inc. stock priceFree Daily Trading Room Entry - jammulinksnews.com
Day One to Report Second Quarter 2025 Financial Results Tuesday, August 5, 2025 - GlobeNewswire
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Shares Sold by Teacher Retirement System of Texas - Defense World
How Day One Biopharmaceuticals Inc. stock performs during market volatilityFree Access to Community - Newser
Why Day One Biopharmaceuticals Inc. stock attracts strong analyst attentionTop Performing Low Risk Stocks - Newser
When the Price of (DAWN) Talks, People Listen - news.stocktradersdaily.com
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Given Average Recommendation of “Buy” by Brokerages - Defense World
Wealth Enhancement Advisory Services LLC Makes New $88,000 Investment in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World
Day One Announces Pricing of Upsized Initial Public Offering - IT Business Net
Day One Biopharmaceuticals, Inc. shares rise 4.16% intraday after positive mid-term outlook from Lonza Group. - AInvest
Day One Biopharmaceuticals Inc Azioni (DAWN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.32%
1.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):